In a recent study including patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention, high Gal-3 concentrations were associated with HF development and rehospitalization both at 1 and 2 years [94]. The gene discussed is LGALS3; the disease is hydrops fetalis.